Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital

J Eur Acad Dermatol Venereol. 2024 Feb;38(2):e193-e194. doi: 10.1111/jdv.19528. Epub 2023 Sep 25.

Authors

C Valente¹, P Farinha¹, B Duarte¹

Affiliation

¹ Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

PMID: 37731014
DOI: 10.1111/jdv.19528

No abstract available

Publication types

Observational Study
Letter

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Prospective Studies
Severity of Illness Index
Tertiary Care Centers
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
dupilumab